Innoviva Inc (INVA)

$15.33 0.40 (2.68%)

14:08 EDT INVA Stock Quote Delayed 30 Minutes

If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Jan 10, 2024

Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month.

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now

7 Undervalued Biotech Stocks to Buy Before They Boom

La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News

Volume:

Previous Close -

Market Cap 1.00B

PE Ratio 36.50

EPS 0.42

Volume (Avg. Vol.) 326,255

Day's Range $14.89 - $15.35

52-Week Range $11.37 - $16.87

Dividend & Yield N/A (N/A)

INVA Stock Predictions, Articles, and Innoviva Inc News

From InvestorPlace
From the Web

10 Stocks to Buy That Could Make You a Millionaire in 2022

By Will Ashworth, InvestorPlace Contributor Jan 26, 2022

After this past year, it's going to be hard to find stocks to buy to make you a millionaire in 2022. Here's 10 that might do the trick.

7 of the Top-Rated Pharmaceutical Stocks for Q1

By Louis Navellier and the InvestorPlace Research Staff Jan 18, 2022

As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks.

7 Top-Rated Pharmaceutical Stocks To Invest in for October

By Louis Navellier and the InvestorPlace Research Staff Oct 4, 2021

It's a great time to look beyond the big name pharmaceutical stocks and look for great niche players with big futures.

4 Undervalued Biotech Stocks That Belong On Every Investor’s Buy List

By Stavros Georgiadis, CFA, InvestorPlace Contributor Jun 17, 2021

Searching for undervalued biotech stocks? Here are 4 biotech stocks to buy for a mix of value and growth in any portfolio.

7 Biotech Stocks to Buy and Hold in 2020

By Chris Lau, InvestorPlace Contributor Mar 16, 2020

Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

5 Undervalued Stocks to Buy

By Chris Lau, InvestorPlace Contributor Dec 18, 2019

These undervalued stocks have been hit hard lately, but they still have what it takes to make a comeback, making them solid stocks to buy.

7 Biotech Stocks to Buy With Plenty of Power in the Pipeline

By Chris Lau, InvestorPlace Contributor Nov 12, 2019

With biotech stocks back in favor, investors may selectively pick only those with a deep drug pipeline ahead.

10 Small-Cap Stocks That Look Like Bargains

By James Brumley, InvestorPlace Feature Writer Jun 28, 2019

Petmed, Innoviva and Pitney Bowes are among some of the best small-cap stocks to buy now, after a recent drubbing.

10 Risky (But Rewarding) Small-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer Apr 5, 2019

These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.

Innoviva names Stephen Basso as finance chief (NASDAQ:INVA)

From Seeking Alpha Aug 25, 2023

Innoviva (INVA) said on Friday that it had appointed Stephen Basso as chief financial officer, effective August 21.More recently, Basso served as the CFO and chief operating officer...

Armata Pharmaceuticals gets $25M in financing and new executive chief (NYSE:ARMP)

From Seeking Alpha Jul 11, 2023

Biotechnology company focused on pathogen‐specific bacteriophage therapeutics for antibiotic‐resistant and difficult‐to‐treat bacterial infections, Armata Pharmaceuticals (ARMP) enters...

(NASDAQ:INVA)

From Seeking Alpha May 9, 2023

Innoviva press release (INVA): Q1 GAAP EPS of $0.51.Revenue of $76.37M (-15.2% Y/Y).Cash and cash equivalents totaled $144.0 million

Innoviva chairman Bickerstaff to step down after annual meeting (NASDAQ:INVA)

From Seeking Alpha Apr 28, 2023

Innoviva (INVA) announced on Friday that chairman George Bickerstaff, III, would not stand for reelection at the company’s 2023 Annual Meeting.After the meeting, assuming that all...

InnovivaEPS of -$0.98, revenue of $65.8M beats by $6.95M (NASDAQ:INVA)

From Seeking Alpha Feb 28, 2023

Innoviva press release (INVA): Q4 EPS of -$0.98 may not be comparable to consensus of $0.25.Revenue of $65.8M (+439.3% Y/Y) beats by $6.95M.

Analysts Offer Insights on Healthcare Companies: Innoviva (INVA) and Envista Holdings (NVST)

From TipRanks Oct 13, 2022

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Innoviva (

Innoviva Inc (INVA)

If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now

7 Undervalued Biotech Stocks to Buy Before They Boom

La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Innoviva Inc (INVA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

INVA Stock Predictions, Articles, and Innoviva Inc News

Subscriber Sign in